- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation.
According to our latest study, the global Blood Plasma Fractionation market size was valued at USD 29140 million in 2022 and is forecast to a readjusted size of USD 47720 million by 2029 with a CAGR of 7.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key blood plasma fractionation players include CSL, Grifols and Takeda etc. The top 3 companies hold a share about 55%. North America is the largest market with a share about 40%, followed by Asia-Pacific and Europe.
In terms of product, Immune Globulin is the largest segment with a share about 50%. And in terms of applications, the largest application is hospital with a share about 70%.
This report is a detailed and comprehensive analysis for global Blood Plasma Fractionation market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Blood Plasma Fractionation market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Blood Plasma Fractionation market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Blood Plasma Fractionation market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Blood Plasma Fractionation market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Plasma Fractionation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Plasma Fractionation market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma and Kedrion, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Blood Plasma Fractionation market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immune Globulin
Coagulation Factor
Albumin
Other
Market segment by Application
Hospital
Retail Pharmacy
Other
Major players covered
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood Plasma Fractionation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Blood Plasma Fractionation, with price, sales, revenue and global market share of Blood Plasma Fractionation from 2018 to 2023.
Chapter 3, the Blood Plasma Fractionation competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood Plasma Fractionation breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Blood Plasma Fractionation market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Blood Plasma Fractionation.
Chapter 14 and 15, to describe Blood Plasma Fractionation sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Blood Plasma Fractionation
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Blood Plasma Fractionation Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Immune Globulin
1.3.3 Coagulation Factor
1.3.4 Albumin
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Blood Plasma Fractionation Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Blood Plasma Fractionation Market Size & Forecast
1.5.1 Global Blood Plasma Fractionation Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Blood Plasma Fractionation Sales Quantity (2018-2029)
1.5.3 Global Blood Plasma Fractionation Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Blood Plasma Fractionation Product and Services
2.1.4 Takeda Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Takeda Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Blood Plasma Fractionation Product and Services
2.2.4 CSL Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments/Updates
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Blood Plasma Fractionation Product and Services
2.3.4 Grifols Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Grifols Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Blood Plasma Fractionation Product and Services
2.4.4 Octapharma Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Octapharma Recent Developments/Updates
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Blood Plasma Fractionation Product and Services
2.5.4 Kedrion Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Kedrion Recent Developments/Updates
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Blood Plasma Fractionation Product and Services
2.6.4 LFB Group Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 LFB Group Recent Developments/Updates
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Blood Plasma Fractionation Product and Services
2.7.4 Biotest Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Biotest Recent Developments/Updates
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Blood Plasma Fractionation Product and Services
2.8.4 BPL Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BPL Recent Developments/Updates
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Blood Plasma Fractionation Product and Services
2.9.4 RAAS Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 RAAS Recent Developments/Updates
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Blood Plasma Fractionation Product and Services
2.10.4 CBPO Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 CBPO Recent Developments/Updates
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Blood Plasma Fractionation Product and Services
2.11.4 Hualan Bio Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hualan Bio Recent Developments/Updates
2.12 Tiantan Bio
2.12.1 Tiantan Bio Details
2.12.2 Tiantan Bio Major Business
2.12.3 Tiantan Bio Blood Plasma Fractionation Product and Services
2.12.4 Tiantan Bio Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Tiantan Bio Recent Developments/Updates
2.13 Shuanglin Bio
2.13.1 Shuanglin Bio Details
2.13.2 Shuanglin Bio Major Business
2.13.3 Shuanglin Bio Blood Plasma Fractionation Product and Services
2.13.4 Shuanglin Bio Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Shuanglin Bio Recent Developments/Updates
2.14 Boya Bio
2.14.1 Boya Bio Details
2.14.2 Boya Bio Major Business
2.14.3 Boya Bio Blood Plasma Fractionation Product and Services
2.14.4 Boya Bio Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Boya Bio Recent Developments/Updates
2.15 Yuanda Shuyang
2.15.1 Yuanda Shuyang Details
2.15.2 Yuanda Shuyang Major Business
2.15.3 Yuanda Shuyang Blood Plasma Fractionation Product and Services
2.15.4 Yuanda Shuyang Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Yuanda Shuyang Recent Developments/Updates
2.16 Weiguang Bio
2.16.1 Weiguang Bio Details
2.16.2 Weiguang Bio Major Business
2.16.3 Weiguang Bio Blood Plasma Fractionation Product and Services
2.16.4 Weiguang Bio Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Weiguang Bio Recent Developments/Updates
2.17 Nanyue Bio
2.17.1 Nanyue Bio Details
2.17.2 Nanyue Bio Major Business
2.17.3 Nanyue Bio Blood Plasma Fractionation Product and Services
2.17.4 Nanyue Bio Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Nanyue Bio Recent Developments/Updates
2.18 KM Biologics
2.18.1 KM Biologics Details
2.18.2 KM Biologics Major Business
2.18.3 KM Biologics Blood Plasma Fractionation Product and Services
2.18.4 KM Biologics Blood Plasma Fractionation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 KM Biologics Recent Developments/Updates
3 Competitive Environment: Blood Plasma Fractionation by Manufacturer
3.1 Global Blood Plasma Fractionation Sales Quantity by Manufacturer (2018-2023)
3.2 Global Blood Plasma Fractionation Revenue by Manufacturer (2018-2023)
3.3 Global Blood Plasma Fractionation Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Blood Plasma Fractionation by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Blood Plasma Fractionation Manufacturer Market Share in 2022
3.4.2 Top 6 Blood Plasma Fractionation Manufacturer Market Share in 2022
3.5 Blood Plasma Fractionation Market: Overall Company Footprint Analysis
3.5.1 Blood Plasma Fractionation Market: Region Footprint
3.5.2 Blood Plasma Fractionation Market: Company Product Type Footprint
3.5.3 Blood Plasma Fractionation Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Blood Plasma Fractionation Market Size by Region
4.1.1 Global Blood Plasma Fractionation Sales Quantity by Region (2018-2029)
4.1.2 Global Blood Plasma Fractionation Consumption Value by Region (2018-2029)
4.1.3 Global Blood Plasma Fractionation Average Price by Region (2018-2029)
4.2 North America Blood Plasma Fractionation Consumption Value (2018-2029)
4.3 Europe Blood Plasma Fractionation Consumption Value (2018-2029)
4.4 Asia-Pacific Blood Plasma Fractionation Consumption Value (2018-2029)
4.5 South America Blood Plasma Fractionation Consumption Value (2018-2029)
4.6 Middle East and Africa Blood Plasma Fractionation Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Blood Plasma Fractionation Sales Quantity by Type (2018-2029)
5.2 Global Blood Plasma Fractionation Consumption Value by Type (2018-2029)
5.3 Global Blood Plasma Fractionation Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Blood Plasma Fractionation Sales Quantity by Application (2018-2029)
6.2 Global Blood Plasma Fractionation Consumption Value by Application (2018-2029)
6.3 Global Blood Plasma Fractionation Average Price by Application (2018-2029)
7 North America
7.1 North America Blood Plasma Fractionation Sales Quantity by Type (2018-2029)
7.2 North America Blood Plasma Fractionation Sales Quantity by Application (2018-2029)
7.3 North America Blood Plasma Fractionation Market Size by Country
7.3.1 North America Blood Plasma Fractionation Sales Quantity by Country (2018-2029)
7.3.2 North America Blood Plasma Fractionation Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Blood Plasma Fractionation Sales Quantity by Type (2018-2029)
8.2 Europe Blood Plasma Fractionation Sales Quantity by Application (2018-2029)
8.3 Europe Blood Plasma Fractionation Market Size by Country
8.3.1 Europe Blood Plasma Fractionation Sales Quantity by Country (2018-2029)
8.3.2 Europe Blood Plasma Fractionation Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Blood Plasma Fractionation Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Blood Plasma Fractionation Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Blood Plasma Fractionation Market Size by Region
9.3.1 Asia-Pacific Blood Plasma Fractionation Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Blood Plasma Fractionation Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Blood Plasma Fractionation Sales Quantity by Type (2018-2029)
10.2 South America Blood Plasma Fractionation Sales Quantity by Application (2018-2029)
10.3 South America Blood Plasma Fractionation Market Size by Country
10.3.1 South America Blood Plasma Fractionation Sales Quantity by Country (2018-2029)
10.3.2 South America Blood Plasma Fractionation Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Blood Plasma Fractionation Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Blood Plasma Fractionation Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Blood Plasma Fractionation Market Size by Country
11.3.1 Middle East & Africa Blood Plasma Fractionation Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Blood Plasma Fractionation Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Blood Plasma Fractionation Market Drivers
12.2 Blood Plasma Fractionation Market Restraints
12.3 Blood Plasma Fractionation Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Blood Plasma Fractionation and Key Manufacturers
13.2 Manufacturing Costs Percentage of Blood Plasma Fractionation
13.3 Blood Plasma Fractionation Production Process
13.4 Blood Plasma Fractionation Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Blood Plasma Fractionation Typical Distributors
14.3 Blood Plasma Fractionation Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Blood Plasma Fractionation Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Blood Plasma Fractionation Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Blood Plasma Fractionation Product and Services
Table 6. Takeda Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Takeda Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Blood Plasma Fractionation Product and Services
Table 11. CSL Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CSL Recent Developments/Updates
Table 13. Grifols Basic Information, Manufacturing Base and Competitors
Table 14. Grifols Major Business
Table 15. Grifols Blood Plasma Fractionation Product and Services
Table 16. Grifols Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Grifols Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Blood Plasma Fractionation Product and Services
Table 21. Octapharma Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Octapharma Recent Developments/Updates
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Blood Plasma Fractionation Product and Services
Table 26. Kedrion Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Kedrion Recent Developments/Updates
Table 28. LFB Group Basic Information, Manufacturing Base and Competitors
Table 29. LFB Group Major Business
Table 30. LFB Group Blood Plasma Fractionation Product and Services
Table 31. LFB Group Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. LFB Group Recent Developments/Updates
Table 33. Biotest Basic Information, Manufacturing Base and Competitors
Table 34. Biotest Major Business
Table 35. Biotest Blood Plasma Fractionation Product and Services
Table 36. Biotest Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Biotest Recent Developments/Updates
Table 38. BPL Basic Information, Manufacturing Base and Competitors
Table 39. BPL Major Business
Table 40. BPL Blood Plasma Fractionation Product and Services
Table 41. BPL Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. BPL Recent Developments/Updates
Table 43. RAAS Basic Information, Manufacturing Base and Competitors
Table 44. RAAS Major Business
Table 45. RAAS Blood Plasma Fractionation Product and Services
Table 46. RAAS Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. RAAS Recent Developments/Updates
Table 48. CBPO Basic Information, Manufacturing Base and Competitors
Table 49. CBPO Major Business
Table 50. CBPO Blood Plasma Fractionation Product and Services
Table 51. CBPO Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. CBPO Recent Developments/Updates
Table 53. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 54. Hualan Bio Major Business
Table 55. Hualan Bio Blood Plasma Fractionation Product and Services
Table 56. Hualan Bio Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Hualan Bio Recent Developments/Updates
Table 58. Tiantan Bio Basic Information, Manufacturing Base and Competitors
Table 59. Tiantan Bio Major Business
Table 60. Tiantan Bio Blood Plasma Fractionation Product and Services
Table 61. Tiantan Bio Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Tiantan Bio Recent Developments/Updates
Table 63. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 64. Shuanglin Bio Major Business
Table 65. Shuanglin Bio Blood Plasma Fractionation Product and Services
Table 66. Shuanglin Bio Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Shuanglin Bio Recent Developments/Updates
Table 68. Boya Bio Basic Information, Manufacturing Base and Competitors
Table 69. Boya Bio Major Business
Table 70. Boya Bio Blood Plasma Fractionation Product and Services
Table 71. Boya Bio Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Boya Bio Recent Developments/Updates
Table 73. Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 74. Yuanda Shuyang Major Business
Table 75. Yuanda Shuyang Blood Plasma Fractionation Product and Services
Table 76. Yuanda Shuyang Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Yuanda Shuyang Recent Developments/Updates
Table 78. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 79. Weiguang Bio Major Business
Table 80. Weiguang Bio Blood Plasma Fractionation Product and Services
Table 81. Weiguang Bio Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Weiguang Bio Recent Developments/Updates
Table 83. Nanyue Bio Basic Information, Manufacturing Base and Competitors
Table 84. Nanyue Bio Major Business
Table 85. Nanyue Bio Blood Plasma Fractionation Product and Services
Table 86. Nanyue Bio Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Nanyue Bio Recent Developments/Updates
Table 88. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 89. KM Biologics Major Business
Table 90. KM Biologics Blood Plasma Fractionation Product and Services
Table 91. KM Biologics Blood Plasma Fractionation Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. KM Biologics Recent Developments/Updates
Table 93. Global Blood Plasma Fractionation Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 94. Global Blood Plasma Fractionation Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Blood Plasma Fractionation Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 96. Market Position of Manufacturers in Blood Plasma Fractionation, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Blood Plasma Fractionation Production Site of Key Manufacturer
Table 98. Blood Plasma Fractionation Market: Company Product Type Footprint
Table 99. Blood Plasma Fractionation Market: Company Product Application Footprint
Table 100. Blood Plasma Fractionation New Market Entrants and Barriers to Market Entry
Table 101. Blood Plasma Fractionation Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Blood Plasma Fractionation Sales Quantity by Region (2018-2023) & (K Units)
Table 103. Global Blood Plasma Fractionation Sales Quantity by Region (2024-2029) & (K Units)
Table 104. Global Blood Plasma Fractionation Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Blood Plasma Fractionation Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Blood Plasma Fractionation Average Price by Region (2018-2023) & (US$/Unit)
Table 107. Global Blood Plasma Fractionation Average Price by Region (2024-2029) & (US$/Unit)
Table 108. Global Blood Plasma Fractionation Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Global Blood Plasma Fractionation Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Global Blood Plasma Fractionation Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Blood Plasma Fractionation Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Blood Plasma Fractionation Average Price by Type (2018-2023) & (US$/Unit)
Table 113. Global Blood Plasma Fractionation Average Price by Type (2024-2029) & (US$/Unit)
Table 114. Global Blood Plasma Fractionation Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Global Blood Plasma Fractionation Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Global Blood Plasma Fractionation Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Blood Plasma Fractionation Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Blood Plasma Fractionation Average Price by Application (2018-2023) & (US$/Unit)
Table 119. Global Blood Plasma Fractionation Average Price by Application (2024-2029) & (US$/Unit)
Table 120. North America Blood Plasma Fractionation Sales Quantity by Type (2018-2023) & (K Units)
Table 121. North America Blood Plasma Fractionation Sales Quantity by Type (2024-2029) & (K Units)
Table 122. North America Blood Plasma Fractionation Sales Quantity by Application (2018-2023) & (K Units)
Table 123. North America Blood Plasma Fractionation Sales Quantity by Application (2024-2029) & (K Units)
Table 124. North America Blood Plasma Fractionation Sales Quantity by Country (2018-2023) & (K Units)
Table 125. North America Blood Plasma Fractionation Sales Quantity by Country (2024-2029) & (K Units)
Table 126. North America Blood Plasma Fractionation Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Blood Plasma Fractionation Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Blood Plasma Fractionation Sales Quantity by Type (2018-2023) & (K Units)
Table 129. Europe Blood Plasma Fractionation Sales Quantity by Type (2024-2029) & (K Units)
Table 130. Europe Blood Plasma Fractionation Sales Quantity by Application (2018-2023) & (K Units)
Table 131. Europe Blood Plasma Fractionation Sales Quantity by Application (2024-2029) & (K Units)
Table 132. Europe Blood Plasma Fractionation Sales Quantity by Country (2018-2023) & (K Units)
Table 133. Europe Blood Plasma Fractionation Sales Quantity by Country (2024-2029) & (K Units)
Table 134. Europe Blood Plasma Fractionation Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Blood Plasma Fractionation Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Blood Plasma Fractionation Sales Quantity by Type (2018-2023) & (K Units)
Table 137. Asia-Pacific Blood Plasma Fractionation Sales Quantity by Type (2024-2029) & (K Units)
Table 138. Asia-Pacific Blood Plasma Fractionation Sales Quantity by Application (2018-2023) & (K Units)
Table 139. Asia-Pacific Blood Plasma Fractionation Sales Quantity by Application (2024-2029) & (K Units)
Table 140. Asia-Pacific Blood Plasma Fractionation Sales Quantity by Region (2018-2023) & (K Units)
Table 141. Asia-Pacific Blood Plasma Fractionation Sales Quantity by Region (2024-2029) & (K Units)
Table 142. Asia-Pacific Blood Plasma Fractionation Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Blood Plasma Fractionation Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Blood Plasma Fractionation Sales Quantity by Type (2018-2023) & (K Units)
Table 145. South America Blood Plasma Fractionation Sales Quantity by Type (2024-2029) & (K Units)
Table 146. South America Blood Plasma Fractionation Sales Quantity by Application (2018-2023) & (K Units)
Table 147. South America Blood Plasma Fractionation Sales Quantity by Application (2024-2029) & (K Units)
Table 148. South America Blood Plasma Fractionation Sales Quantity by Country (2018-2023) & (K Units)
Table 149. South America Blood Plasma Fractionation Sales Quantity by Country (2024-2029) & (K Units)
Table 150. South America Blood Plasma Fractionation Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Blood Plasma Fractionation Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Blood Plasma Fractionation Sales Quantity by Type (2018-2023) & (K Units)
Table 153. Middle East & Africa Blood Plasma Fractionation Sales Quantity by Type (2024-2029) & (K Units)
Table 154. Middle East & Africa Blood Plasma Fractionation Sales Quantity by Application (2018-2023) & (K Units)
Table 155. Middle East & Africa Blood Plasma Fractionation Sales Quantity by Application (2024-2029) & (K Units)
Table 156. Middle East & Africa Blood Plasma Fractionation Sales Quantity by Region (2018-2023) & (K Units)
Table 157. Middle East & Africa Blood Plasma Fractionation Sales Quantity by Region (2024-2029) & (K Units)
Table 158. Middle East & Africa Blood Plasma Fractionation Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Blood Plasma Fractionation Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Blood Plasma Fractionation Raw Material
Table 161. Key Manufacturers of Blood Plasma Fractionation Raw Materials
Table 162. Blood Plasma Fractionation Typical Distributors
Table 163. Blood Plasma Fractionation Typical Customers
List of Figures
Figure 1. Blood Plasma Fractionation Picture
Figure 2. Global Blood Plasma Fractionation Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Blood Plasma Fractionation Consumption Value Market Share by Type in 2022
Figure 4. Immune Globulin Examples
Figure 5. Coagulation Factor Examples
Figure 6. Albumin Examples
Figure 7. Other Examples
Figure 8. Global Blood Plasma Fractionation Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Blood Plasma Fractionation Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Retail Pharmacy Examples
Figure 12. Other Examples
Figure 13. Global Blood Plasma Fractionation Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Blood Plasma Fractionation Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Blood Plasma Fractionation Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Blood Plasma Fractionation Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Blood Plasma Fractionation Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Blood Plasma Fractionation Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Blood Plasma Fractionation by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Blood Plasma Fractionation Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Blood Plasma Fractionation Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Blood Plasma Fractionation Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Blood Plasma Fractionation Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Blood Plasma Fractionation Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Blood Plasma Fractionation Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Blood Plasma Fractionation Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Blood Plasma Fractionation Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Blood Plasma Fractionation Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Blood Plasma Fractionation Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Blood Plasma Fractionation Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Blood Plasma Fractionation Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Blood Plasma Fractionation Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Blood Plasma Fractionation Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Blood Plasma Fractionation Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Blood Plasma Fractionation Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Blood Plasma Fractionation Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Blood Plasma Fractionation Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Blood Plasma Fractionation Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Blood Plasma Fractionation Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Blood Plasma Fractionation Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Blood Plasma Fractionation Consumption Value Market Share by Region (2018-2029)
Figure 55. China Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Blood Plasma Fractionation Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Blood Plasma Fractionation Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Blood Plasma Fractionation Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Blood Plasma Fractionation Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Blood Plasma Fractionation Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Blood Plasma Fractionation Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Blood Plasma Fractionation Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Blood Plasma Fractionation Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Blood Plasma Fractionation Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Blood Plasma Fractionation Market Drivers
Figure 76. Blood Plasma Fractionation Market Restraints
Figure 77. Blood Plasma Fractionation Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Blood Plasma Fractionation in 2022
Figure 80. Manufacturing Process Analysis of Blood Plasma Fractionation
Figure 81. Blood Plasma Fractionation Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
